Cell-free DNA Fragmentomics Assay to Discriminate the Malignancy of Breast Nodules and Evaluate Treatment Response
View ORCID ProfileJiaqi Liu, View ORCID ProfileYalun Li, View ORCID ProfileWanxiangfu Tang, View ORCID ProfileLijun Dai, View ORCID ProfileZiqi Jia, View ORCID ProfileHeng Cao, View ORCID ProfileChenghao Li, View ORCID ProfileYuchen Liu, View ORCID ProfileYansong Huang, View ORCID ProfileJiang Wu, View ORCID ProfileDongxu Ma, View ORCID ProfileGuangdong Qiao, View ORCID ProfileHua Bao, View ORCID ProfileShuang Chang, View ORCID ProfileDongqin Zhu, View ORCID ProfileShanshan Yang, View ORCID ProfileXuxiaochen Wu, View ORCID ProfileXue Wu, View ORCID ProfileHengyi Xu, View ORCID ProfileHongyan Chen, View ORCID ProfileYang Shao, View ORCID ProfileXiang Wang, View ORCID ProfileZhihua Liu, View ORCID ProfileJianzhong Su
doi: https://doi.org/10.1101/2024.10.15.24315518
Jiaqi Liu
1State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
2Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Eye Hospital, Wenzhou Medical University, Wenzhou 325027, China
3Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
Yalun Li
4Department of Breast Surgery, the Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai 264000, China
Wanxiangfu Tang
5Nanjing Geneseeq Technology Inc., Nanjing 210061, China
Lijun Dai
2Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Eye Hospital, Wenzhou Medical University, Wenzhou 325027, China
Ziqi Jia
3Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
Heng Cao
3Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
Chenghao Li
2Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Eye Hospital, Wenzhou Medical University, Wenzhou 325027, China
Yuchen Liu
3Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
6School of Clinical Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100005, China
Yansong Huang
3Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
6School of Clinical Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100005, China
Jiang Wu
3Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
Dongxu Ma
3Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
Guangdong Qiao
4Department of Breast Surgery, the Affiliated Yantai Yuhuangding Hospital of Qingdao University, Yantai 264000, China
Hua Bao
5Nanjing Geneseeq Technology Inc., Nanjing 210061, China
Shuang Chang
5Nanjing Geneseeq Technology Inc., Nanjing 210061, China
Dongqin Zhu
5Nanjing Geneseeq Technology Inc., Nanjing 210061, China
Shanshan Yang
5Nanjing Geneseeq Technology Inc., Nanjing 210061, China
Xuxiaochen Wu
5Nanjing Geneseeq Technology Inc., Nanjing 210061, China
Xue Wu
5Nanjing Geneseeq Technology Inc., Nanjing 210061, China
Hengyi Xu
1State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
6School of Clinical Medicine, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100005, China
Hongyan Chen
1State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
Yang Shao
5Nanjing Geneseeq Technology Inc., Nanjing 210061, China
Xiang Wang
3Department of Breast Surgical Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
Zhihua Liu
1State Key Laboratory of Molecular Oncology, National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China
Jianzhong Su
2Oujiang Laboratory (Zhejiang Lab for Regenerative Medicine, Vision and Brain Health), Eye Hospital, Wenzhou Medical University, Wenzhou 325027, China
Article usage
Posted October 17, 2024.
Cell-free DNA Fragmentomics Assay to Discriminate the Malignancy of Breast Nodules and Evaluate Treatment Response
Jiaqi Liu, Yalun Li, Wanxiangfu Tang, Lijun Dai, Ziqi Jia, Heng Cao, Chenghao Li, Yuchen Liu, Yansong Huang, Jiang Wu, Dongxu Ma, Guangdong Qiao, Hua Bao, Shuang Chang, Dongqin Zhu, Shanshan Yang, Xuxiaochen Wu, Xue Wu, Hengyi Xu, Hongyan Chen, Yang Shao, Xiang Wang, Zhihua Liu, Jianzhong Su
medRxiv 2024.10.15.24315518; doi: https://doi.org/10.1101/2024.10.15.24315518
Cell-free DNA Fragmentomics Assay to Discriminate the Malignancy of Breast Nodules and Evaluate Treatment Response
Jiaqi Liu, Yalun Li, Wanxiangfu Tang, Lijun Dai, Ziqi Jia, Heng Cao, Chenghao Li, Yuchen Liu, Yansong Huang, Jiang Wu, Dongxu Ma, Guangdong Qiao, Hua Bao, Shuang Chang, Dongqin Zhu, Shanshan Yang, Xuxiaochen Wu, Xue Wu, Hengyi Xu, Hongyan Chen, Yang Shao, Xiang Wang, Zhihua Liu, Jianzhong Su
medRxiv 2024.10.15.24315518; doi: https://doi.org/10.1101/2024.10.15.24315518
Subject Area
Subject Areas
- Addiction Medicine (399)
- Allergy and Immunology (709)
- Anesthesia (201)
- Cardiovascular Medicine (2944)
- Dermatology (249)
- Emergency Medicine (440)
- Epidemiology (12744)
- Forensic Medicine (12)
- Gastroenterology (828)
- Genetic and Genomic Medicine (4583)
- Geriatric Medicine (417)
- Health Economics (729)
- Health Informatics (2917)
- Health Policy (1069)
- Hematology (389)
- HIV/AIDS (924)
- Medical Education (426)
- Medical Ethics (115)
- Nephrology (469)
- Neurology (4354)
- Nursing (236)
- Nutrition (639)
- Oncology (2268)
- Ophthalmology (646)
- Orthopedics (258)
- Otolaryngology (325)
- Pain Medicine (279)
- Palliative Medicine (83)
- Pathology (501)
- Pediatrics (1196)
- Primary Care Research (496)
- Public and Global Health (6938)
- Radiology and Imaging (1527)
- Respiratory Medicine (915)
- Rheumatology (437)
- Sports Medicine (385)
- Surgery (489)
- Toxicology (60)
- Transplantation (212)
- Urology (181)